Company OrbusNeich Medical Group Holdings Limited
Equities
6929
KYG6773B1005
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.42 HKD | -1.34% |
|
-3.07% | -37.30% |
03-07 | OrbusNeich Medical Group’s Profit Up 144% in 2023 | MT |
03-07 | OrbusNeich Medical Group Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 1,249
Sales per Business
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Coronary Interventional Medical Devices - Balloon - Scoring
36.7
%
| 398 | 37.1 % | 442 | 36.7 % | +11.23% |
Coronary Interventional Medical Devices - Balloon - Semi-compliant
19.6
%
| 208 | 19.4 % | 236 | 19.6 % | +13.72% |
Coronary Interventional Medical Devices - Balloon - Non-compliant
18.6
%
| 200 | 18.7 % | 225 | 18.6 % | +12.09% |
Peripheral Interventional Medical Devices - Balloon
9.6
%
| 89 | 8.3 % | 115 | 9.6 % | +28.94% |
Coronary Interventional Medical Devices - Stent
7.7
%
| 99 | 9.3 % | 93 | 7.7 % | -6.09% |
Third Party Products
3.9
%
| 42 | 4.0 % | 46 | 3.9 % | +9.44% |
Other Medical Accessories
3.9
%
| 34 | 3.2 % | 46 | 3.9 % | +34.72% |
Sales per region
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Japan
24.7
%
| 254 | 23.7 % | 298 | 24.7 % | +17.13% |
Europe, Middle East & Africa
23.6
%
| 253 | 23.6 % | 285 | 23.6 % | +12.61% |
Asia Pacific Region
23.6
%
| 250 | 23.3 % | 285 | 23.6 % | +13.98% |
China
14.2
%
| 185 | 17.2 % | 171 | 14.2 % | -7.27% |
United States
13.8
%
| 130 | 12.1 % | 166 | 13.8 % | +27.91% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Chien
CEO | Chief Executive Officer | 59 | 21/07/21 |
Wing Shing Chen
DFI | Director of Finance/CFO | 43 | 21/07/21 |
Robert Cottone
CTO | Chief Tech/Sci/R&D Officer | 61 | - |
Kwai Ching Lau
COO | Chief Operating Officer | 50 | 21/07/21 |
Ching Chung Chow
BRD | Director/Board Member | 66 | 21/07/21 |
Alain Khair
PRN | Corporate Officer/Principal | 54 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Chien
CEO | Chief Executive Officer | 59 | 21/07/21 |
Yip Keung Chan
BRD | Director/Board Member | 40 | 28/09/21 |
Ka Keung Lau
BRD | Director/Board Member | 48 | 28/09/21 |
Yi Zhou
BRD | Director/Board Member | 44 | 27/09/21 |
Lai Fan Tam
BRD | Director/Board Member | 67 | 28/09/21 |
Kwai Ching Lau
COO | Chief Operating Officer | 50 | 21/07/21 |
Wing Shing Chen
DFI | Director of Finance/CFO | 43 | 21/07/21 |
Ching Chung Chow
BRD | Director/Board Member | 66 | 21/07/21 |
Ting San Leung
BRD | Director/Board Member | - | 22/05/23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 827,968,337 | 306,137,350 ( 36.97 %) | 0 | 36.97 % |
Company contact information
OrbusNeich Medical Group Holdings Ltd.
Units 303 & 305 3/F, Building 20E
, Hong Kong
+852 2802 2288
![address OrbusNeich Medical Group Holdings Limited(6929)](https://cdn.zonebourse.com/static/address/148356443.png)
Sector
Sales per Business
Sales per region
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-37.30% | 474M | |
+13.39% | 129B | |
-9.21% | 10.82B | |
-16.57% | 7.12B | |
+41.54% | 5.66B | |
-31.48% | 4.14B | |
+8.95% | 3.46B | |
-19.67% | 2.47B | |
-16.74% | 1.95B | |
-23.55% | 1.7B |
- Stock Market
- Equities
- 6929 Stock
- Company OrbusNeich Medical Group Holdings Limited